Publications

Bouchra Derraz, Gabriele Breda, Christoph Kaempf, Franziska Baenke, Fabienne Cotte, Kristin Reiche, Ulrike Köhl, Jakob Nikolas Kather, Deborah Eskenazy, and Stephen Gilbert. New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology. npj Precision Oncology, (8)1Springer Science and Business Media LLC, January 2024. [PUMA: drug oncology thinking therapies precision regulatory from:scadsfct AI-based cell] URL

Bouchra Derraz, Gabriele Breda, Christoph Kaempf, Franziska Baenke, Fabienne Cotte, Kristin Reiche, Ulrike Köhl, Jakob Nikolas Kather, Deborah Eskenazy, and Stephen Gilbert. New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology. npj Precision Oncology, (8)1Springer Science and Business Media LLC, January 2024. [PUMA: AI-based cell drug oncology precision regulatory therapies thinking] URL

Didem Cifci, Sebastian Foersch, and Jakob Nikolas Kather. Artificial intelligence to identify genetic alterations in conventional histopathology. J. Pathol., (257)4:430--444, Wiley, July 2022. [PUMA: topic_lifescience analysis; artificial biomarker; image intelligence; oncology precision]